As another year draws to a close, policymakers, researchers, and partners are convening in South Africa to discuss typhoid, TCV, and the work that remains to combat this disease. Despite ...
Read more
As another year draws to a close, policymakers, researchers, and partners are convening in South Africa to discuss typhoid, TCV, and the work that remains to combat this disease. Despite ...
Read moreVASE expands its scope Hundreds of scientists, public health professionals, immunization leaders, vaccine industry representatives, international donors, and other global experts gathered in Washington D.C. for the 2022 Vaccines Against ...
Read moreBackground on test-negative design Typhoid continues to be a public health threat in sub-Saharan Africa. However, typhoid conjugate vaccine (TCV) is a proven intervention to reduce the burden of typhoid ...
Read moreGetting sick comes with costs—both physical as well as economic. Treatment costs and lost wages while recuperating or taking care of a sick family member can be detrimental to families. ...
Read moreWhy drug resistance should be on our radar Drug resistance occurs when bacteria, viruses, fungi, and parasites change over time and no longer respond to treatment. As a result, medicines ...
Read moreLast month in Kericho, Kenya, our team was proud to launch a Phase 3 study of the EuTCV typhoid conjugate vaccine (TCV) candidate. As principal investigators based at Kenya Medical ...
Read moreToday, Pakistan began their final typhoid conjugate vaccine (TCV) introduction campaign to ensure that children are protected against typhoid. This is a major achievement and fulfills a commitment from the ...
Read moreEnvironmental impacts on human health Droughts, floods, earthquakes—disasters our planet knows all too well. We have seen how these disasters have dramatic impacts on the health of communities. The recent ...
Read moreTyphoid conjugate vaccine (TCV) is highly immunogenic in Malawian children as young as 9 months of age! New data show TCV elicits a strong immune response among both young children ...
Read moreTyphoid remains extremely challenging to diagnose. The current gold standard diagnostic is laboratory confirmed blood culture. These tests are difficult to perform and require specialized laboratory skills and facilities. Many ...
Read more